Beactica Therapeutics announces collaboration with the National Center for Advancing Translational Sciences

Contributed by: PR Newswire

Tags

BeacticaTherapeutics

More Like This

Beactica Therapeutics' TEAD programme selected for late-breaking research presentation at the AACR Annual Meeting 2024

NuCana Announces Presentations at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023

Biocytogen Announces IDEAYA’s Nomination of Development Candidate IDE034, a Potential First-in-Class B7H3/PTK7 Topo-I-Payload Bispecific ADC and Option Exercise

Biocytogen Enters Collaboration with ABL Bio to Develop New Bispecific Antibody-Drug Conjugates

BioArctic and Eisai sign research evaluation agreement regarding BAN2802

Biocytogen Announces Option and License Agreement with IDEAYA Biosciences for Potential First-in-Class B7H3/PTK7 Topo-I-Payload Bispecific ADC Program

Petosemtamab granted Breakthrough Therapy Designation by the U.S. FDA

NuCana to Participate in the Truist Securities 2023 BioPharma Symposium